Atlas Trials

Evaluating Neostigmine Effect on Reducing Gastric Residual Volume as Compared With Metoclopramide and Ondansetron

Clinical trial NCT05342818 · COMPLETED

Trial details

NCT number
NCT05342818
Sponsor
Tanta University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Delayed Gastric Emptying
Start date
2022-04-15
Primary completion
2022-07-30
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.